Intervention

Thoracic radiotherapy

ClinicalTrials.gov intervention label

Clinical trials12

Recruiting3

Common conditions17

Lead sponsors shown11

Clinical trials

12 shown

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid BiopsyNCT06869239 · 2025-02-25

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLCNCT06536868 · 2024-08-01

Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With AtezolizumabNCT06771518 · 2021-12-15

PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC PatientsNCT05651802 · 2023-01-01

A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung CancerNCT05353257 · 2022-05-17

ACTIVE_NOT_RECRUITING

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung CancerNCT05223647 · 2022-01-11

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).NCT04472949 · 2021-06-25

ACTIVE_NOT_RECRUITING

Thoracic Radiotherapy Plus EGFR-TKI for Stage III EGFR-mutant Lung AdenocarcinomaNCT07857694 · 2020-01-01

Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung CancerNCT03673657 · 2018-08-10

Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLCNCT04530708 · 2017-02-01

Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning.NCT04863027 · 2015-01-01

Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)NCT01091376 · 2010-01-01

Common conditions

Lung Cancer2 Small Cell Lung Cancer2 EGFR Activating Mutation1 Extensive-stage Small-cell Lung Cancer1 Limited-Stage Small Cell Lung Cancer1 Limited-stage Small Cell Lung Cancer (LS-SCLC)1 Local Advanced Non-small Cell Lung Cancer1 Lung Cancer Stage III1 Lung Function Decreased1 Non Small Cell Lung Cancer1 Non-small Cell Lung Cancer1 Quality of Life1 Radiation Pneumonitis1 Radiotherapy1 Small Cell Lung Cancer Limited Stage1 Small-cell Lung Cancer1 Stage IV Non-small Cell Lung Cancer1

Leading sponsors

Zhejiang Cancer Hospital2 Centre hospitalier de l'Université de Montréal (CHUM)1 Laibin People's Hospital1 Norwegian University of Science and Technology1 Peking University Cancer Hospital & Institute1 Regina Elena Cancer Institute1 Second Hospital of Shanxi Medical University1 Shanghai Henlius Biotech1 Sun Yat-sen University1 Swedish Lung Cancer Study Group1 Swiss Cancer Institute1

Trial status mix

COMPLETED3

RECRUITING3

UNKNOWN3

ACTIVE_NOT_RECRUITING2

TERMINATED1

Phase mix

PHASE25

NA2

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.